Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-19 6:09 pm Sale | 2024-12-17 | 13D | Skye Bioscience, Inc. SKYE | 5AM Partners VII, LLC | 11,696,895 36.400% | -207,168 (-1.74%) | Filing History |
| 2024-11-14 10:02 am Sale | 2024-09-30 | 13G | Skye Bioscience, Inc. SKYE | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -1,727,680 (Position Closed) | Filing History |
| 2024-11-14 09:21 am Purchase | 2024-09-30 | 13G | Skye Bioscience, Inc. SKYE | Altium Capital Management LP | 1,315,146 4.300% | 13,628 (+1.05%) | Filing History |
| 2024-08-14 4:59 pm Purchase | 2024-08-09 | 13G | Skye Bioscience, Inc. SKYE | JANUS HENDERSON GROUP PLC JHG | 1,727,680 5.700% | 1,727,680 (New Position) | Filing History |
| 2024-03-13 7:28 pm Purchase | 2024-03-13 | 13D | Skye Bioscience, Inc. SKYE | 5AM Partners VII, LLC | 11,904,063 40.000% | 457,499 (+4.00%) | Filing History |
| 2024-02-08 09:51 am Purchase | 2024-01-29 | 13G | Skye Bioscience, Inc. SKYE | SPHERA FUNDS MANAGEMENT LTD. | 1,301,518 5.390% | 1,301,518 (New Position) | Filing History |
| 2024-02-02 6:09 pm Purchase | 2024-01-29 | 13G | Skye Bioscience, Inc. SKYE | Altium Capital Management LP | 1,301,518 5.400% | 1,301,518 (New Position) | Filing History |
| 2024-01-31 4:15 pm Purchase | 2024-01-29 | 13D | Skye Bioscience, Inc. SKYE | 5AM Partners VII, LLC | 11,446,564 44.200% | 11,446,564 (New Position) | Filing History |
| 2023-08-28 4:17 pm Purchase | 2023-08-18 | 13G | Skye Bioscience, Inc. SKYE | Versant Venture Capital III L.P. | 2,530,949 19.700% | 2,530,949 (New Position) | Filing History |
| 2023-08-28 4:16 pm Purchase | 2023-08-18 | 13D | Skye Bioscience, Inc. SKYE | 5AM Partners VII, LLC | 6,228,821 44.400% | 6,228,821 (New Position) | Filing History |
| 2023-03-17 5:56 pm Purchase | 2023-02-23 | 13D | EMERALD BIOSCIENCE INC EMBI | Emerald Health Sciences Inc. | 169,407,901 17.400% | 45,126,967 (+36.31%) | Filing History |
| 2022-01-31 1:52 pm Purchase | 2022-01-27 | 13D | EMERALD BIOSCIENCE INC EMBI | Emerald Health Sciences Inc. | 124,280,934 23.400% | 231,108 (+0.19%) | Filing History |
| 2022-01-05 1:05 pm Purchase | 2021-12-31 | 13G | Skye Bioscience, Inc. SKYE | SABBY MANAGEMENT, LLC | 8,000 11.000% | 8,000 (New Position) | Filing History |
| 2021-02-16 5:29 pm Purchase | 2020-12-31 | 13G | Skye Bioscience, Inc. SKYE | ARMISTICE CAPITAL LLC | 50,413 4.990% | 50,413 (New Position) | Filing History |
| 2021-02-05 4:59 pm Sale | 2020-12-31 | 13G | EMERALD BIOSCIENCE INC EMBI | BIGGER CAPITAL FUND L P | 8,167,167 3.300% | -6,000,500 (-42.35%) | Filing History |
| 2021-01-07 08:50 am Sale | 2020-12-31 | 13G | EMERALD BIOSCIENCE INC EMBI | SABBY MANAGEMENT, LLC | 14,480,000 11.000% | -520,000 (-3.47%) | Filing History |
| 2020-08-14 6:37 pm Sale | 2020-08-07 | 13D | EMERALD BIOSCIENCE INC EMBI | Emerald Health Sciences Inc. | 124,049,826 49.200% | -2,440,341 (-1.93%) | Filing History |
| 2020-08-10 4:42 pm Purchase | 2020-07-31 | 13G | EMERALD BIOSCIENCE INC EMBI | ARMISTICE CAPITAL LLC | 15,187,057 6.300% | 15,187,057 (New Position) | Filing History |
| 2020-08-06 5:43 pm Purchase | 2020-07-31 | 13G | EMERALD BIOSCIENCE INC EMBI | BIGGER CAPITAL FUND L P | 14,167,667 5.900% | 14,167,667 (New Position) | Filing History |
| 2020-07-31 12:02 pm Purchase | 2020-07-31 | 13G | EMERALD BIOSCIENCE INC EMBI | SABBY MANAGEMENT, LLC | 15,000,000 11.000% | 15,000,000 (New Position) | Filing History |